Raymond James & Associates’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,968
| Closed | -$10.1K | – | 3841 |
|
|
2023
Q1 | $10.1K | Sell |
2,968
-400
| -12% | -$1.36K | ﹤0.01% | 3786 |
|
|
2022
Q4 | $15.2K | Sell |
3,368
-1,806
| -35% | -$8.13K | ﹤0.01% | 3735 |
|
|
2022
Q3 | $46K | Buy |
5,174
+50
| +1% | +$445 | ﹤0.01% | 3667 |
|
|
2022
Q2 | $59K | Buy |
5,124
+769
| +18% | +$8.86K | ﹤0.01% | 3714 |
|
|
2022
Q1 | $76K | Buy |
4,355
+838
| +24% | +$14.6K | ﹤0.01% | 3802 |
|
|
2021
Q4 | $114K | Buy |
+3,517
| New | +$114K | ﹤0.01% | 3797 |
|
|
2020
Q4 | – | Sell |
-3,310
| Closed | -$66K | – | 3671 |
|
|
2020
Q3 | $66K | Buy |
3,310
+115
| +4% | +$2.29K | ﹤0.01% | 3381 |
|
|
2020
Q2 | $67K | Buy |
+3,195
| New | +$67K | ﹤0.01% | 3297 |
|